Home / Company / About us
About GANGDONG GROUP

A histopathology manufacturer from Korea

Founded in 2014, GANGDONG GROUP develops, manufactures and supplies reagents and consumables for histopathology, molecular and cytology laboratories in Korea and around the world.

2014

Founded

Started as Gangdong Trading, incorporated in 2016.

140+

Customers in Korea

Hospitals, laboratories, universities and CROs.

1.8M

Units per month

Production capacity on automated filling lines.

Only

Maker in Korea

Of both histopathology reagents and consumables.

“We began in 2014 making histopathology products and reagents for Korean laboratories. Today we are growing into a leading manufacturer of pathology and molecular diagnostic reagents and research supplies, and we will keep working to become Korea’s leading bio company.”

Chief Executive Officer, GANGDONG GROUP

Our core values

How we work with customers, partners and each other.

Mutual growth

We build business on mutual benefit, respect and cooperation. Partnerships grow further than buyer and seller relationships, which made us Korea’s histopathology reagent specialist.

Inquiry

We research until we find what laboratories need. Our formalin-free fixative FIXUP® took about six years of research and testing, and we keep combining new ideas and technology to lead the field.

Global direction

We were the first Korean company to export histopathology consumables to the United States, a market with over half of global demand. We continue to expand our range toward a 30% global share target.

History

From trading company to manufacturer

Key milestones since our founding in 2014.

2026

  • OctoberExports surpassed 41 countries
  • SeptemberExhibited at NSH 2026 in San Antonio, Texas (Booth #809)
  • JulyExhibited at WHX Osaka 2026 in Japan
  • AprilSigned a cooperation agreement with Cheongju University
  • MarchOfficially launched the upgraded GDxDORCO microtome blades
  • FebruarySigned a partnership agreement with U2Bio Co., Ltd.

2025

  • ExhibitionsExhibited at the NSH Convention in the United States and the KSHC Conference in Korea

2024

  • NovemberCompleted 1,628-day joint development of microtome blades with DORCO

2023

  • JulyFiled overseas applications for the dual spray head
  • MayExhibited at the KSHC Spring Conference
  • MarchCertified as a Main-Biz company (management innovation)
  • FebruaryFiled patent for tissue cassettes; overseas patents for the dual spray head and tissue cassettes

2022

  • NovemberReceived the Family-Friendly Management award from the Ministry of Culture, Sports and Tourism
  • NovemberIntroduced robotic arm automation across all production processes
  • OctoberFirst Korean company to exhibit at the NSH Convention
  • OctoberExhibited at IFBLS 2022
  • AugustCompleted the first integrated manufacturing and logistics center in Eumseong

2021

  • DecemberReceived the US$10 Million Export Tower
  • JuneSigned an investment agreement with Eumseong County, Chungcheongbuk-do

2020

  • DecemberReceived the US$5 Million Export Tower and a commendation from the Ministry of Trade, Industry and Energy
  • DecemberCertified to ISO 9001, ISO 14001 and ISO 13485
  • JulyCorporate R&D department recognized

2019

  • DecemberRelocated headquarters

2018

  • DecemberLaunched the GD LABWARE consumables brand
  • AugustLaunched the GD CHEM reagent brand
  • JanuaryLaunched Gangdong Science, distributing to Korean universities and research institutes

2017

  • AugustSelected as a partner of SHOEI, a Japanese histopathology consumables company
  • JulySigned an MOU with Falma, a Japanese histopathology equipment company

2016

  • OctoberRenamed Gangdong Group and incorporated as a corporation

2014

  • JanuaryGangdong Trading founded

Company Overview

Since our inception, we have advanced organizations across sectors by pairing strategic insight with disciplined execution.

Proven Expertise

Decades of combined experience underpin every recommendation we issue.

Comprehensive Solutions

Integrated teams eliminate handoff delays and data silos.

Our multidisciplinary team analyzes each objective, designs a tailored roadmap, and implements with rigorous oversight.We prioritize transparent dialogue, enabling stakeholders to monitor performance in real time and refine priorities seamlessly.


Initiate a Productive Dialogue